Assembly Biosciences (ASMB) Stock Statistics & Valuation Metrics

Assembly Biosciences has a market cap or net worth of $466.84M. The enterprise value is $404.35M.

Assembly Biosciences has 15,862,705 shares outstanding. The number of shares has decreased by -2.65% in one year.

Assembly Biosciences’s return on equity (ROE) is -0.03 and return on invested capital (ROIC) is -5.79%.

The current PE Ratio of Assembly Biosciences is ―. Assembly Biosciences’s PEG ratio is 0.68.

In the last 12 months, Assembly Biosciences had revenue of 72.30M and earned -6.12M in profits. Earnings per share was -0.55.

In the last 12 months, operating cash flow was -41.09M and capital expenditures -66.00K, giving a free cash flow of -41.16M billion.

Assembly Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Assembly Biosciences upcoming earnings date is May 7, 2026, After Close (Confirmed).

Assembly Biosciences as a current ratio of 5.22, with Debt / Equity ratio of 1.27%

In the past 12 months, Assembly Biosciences has paid 0.00 in taxes.

Assembly Biosciences EV to EBITDA ratio is -27.15, with an EV/FCF ratio of -7.91.

Assembly Biosciences has $248.11M in cash and marketable securities with $2.63M in debt, giving a net cash position of $245.48M billion.

Gross margin is 77.65%, with operating margin of -16.76%, and net profit margin of -8.47%.

The average price target for Assembly Biosciences is $45.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy